Zebene E, Lombardi R, Pucci B, Medhin H, Seife E, Di Gennaro E
Int J Mol Sci. 2024; 25(23).
PMID: 39684225
PMC: 11641594.
DOI: 10.3390/ijms252312513.
Drew Y, Zenke F, Curtin N
Nat Rev Drug Discov. 2024; 24(1):19-39.
PMID: 39533099
DOI: 10.1038/s41573-024-01060-w.
Jeyagaran A, Urbanczyk M, Carvajal-Berrio D, Baldissera T, Kaiser P, Kuhlburger L
Adv Healthc Mater. 2024; 14(2):e2403017.
PMID: 39511898
PMC: 11730087.
DOI: 10.1002/adhm.202403017.
Alvarez-Gonzalez E, Sierra L
Int J Mol Sci. 2024; 25(16).
PMID: 39201738
PMC: 11355010.
DOI: 10.3390/ijms25169054.
Tuffaha M, Castellano D, Serrano Colome C, Gutenkunst R, Wahl L
bioRxiv. 2024; .
PMID: 38746331
PMC: 11092619.
DOI: 10.1101/2024.04.30.591900.
Role of MicroRNA in Hypoxic Tumours and their Potential as Biomarkers for Early Detection of Cancer.
Jayashree P, Kalpita M, Judith T, Singh A, Ashwin K
Curr Mol Med. 2024; 24(5):525-536.
PMID: 38310548
DOI: 10.2174/0115665240268661231128094831.
Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization.
Zhang Y, Liang L, Li Z, Huang Y, Jiang M, Zou B
Front Oncol. 2023; 13:1295579.
PMID: 38111536
PMC: 10726039.
DOI: 10.3389/fonc.2023.1295579.
PARP inhibitors combined with radiotherapy: are we ready?.
Sun C, Chu A, Song R, Liu S, Chai T, Wang X
Front Pharmacol. 2023; 14:1234973.
PMID: 37954854
PMC: 10637512.
DOI: 10.3389/fphar.2023.1234973.
How to 19F MRI: applications, technique, and getting started.
Maxouri O, Bodalal Z, Daal M, Rostami S, Rodriguez I, Akkari L
BJR Open. 2023; 5(1):20230019.
PMID: 37953866
PMC: 10636348.
DOI: 10.1259/bjro.20230019.
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens.
Srivastava N, Usmani S, Subbarayan R, Saini R, Pandey P
Front Oncol. 2023; 13:1199105.
PMID: 37492478
PMC: 10363988.
DOI: 10.3389/fonc.2023.1199105.
Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis.
Phua T
Front Aging. 2023; 4:1196648.
PMID: 37384143
PMC: 10293850.
DOI: 10.3389/fragi.2023.1196648.
Radio-resistance of hypoxic tumors: exploring the effects of oxygen and x-ray radiation on non-small lung cancer cell lines.
Hanley R, Pagliari F, Garcia-Calderon D, Guerreiro J, Genard G, Jansen J
Radiat Oncol. 2023; 18(1):81.
PMID: 37173741
PMC: 10182694.
DOI: 10.1186/s13014-023-02275-8.
Hypoxia-Related lncRNA Prognostic Model of Ovarian Cancer Based on Big Data Analysis.
Zhang Y, Zhang J, Wang F, Wang L
J Oncol. 2023; 2023:6037121.
PMID: 37064863
PMC: 10104744.
DOI: 10.1155/2023/6037121.
Molecular Regulation of the Response of Brain Pericytes to Hypoxia.
Carlsson R, Enstrom A, Paul G
Int J Mol Sci. 2023; 24(6).
PMID: 36982744
PMC: 10053233.
DOI: 10.3390/ijms24065671.
Chronic hypoxia is associated with transcriptomic reprogramming and increased genomic instability in cancer cells.
Abou Khouzam R, Sharda M, Rao S, Kyerewah-Kersi S, Zeinelabdin N, Mahmood A
Front Cell Dev Biol. 2023; 11:1095419.
PMID: 36968212
PMC: 10033758.
DOI: 10.3389/fcell.2023.1095419.
Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy.
Abou Khouzam R, Lehn J, Mayr H, Clavien P, Wallace M, Ducreux M
Cancers (Basel). 2023; 15(4).
PMID: 36831579
PMC: 9953896.
DOI: 10.3390/cancers15041235.
Genes Involved in DNA Repair and Mitophagy Protect Embryoid Bodies from the Toxic Effect of Methylmercury Chloride under Physioxia Conditions.
Augustyniak J, Kozlowska H, Buzanska L
Cells. 2023; 12(3).
PMID: 36766732
PMC: 9913246.
DOI: 10.3390/cells12030390.
Harnessing the therapeutic vulnerability of MMR heterogeneity in colorectal cancer.
Anandappa G, Overman M
Cell Rep Med. 2023; 4(1):100908.
PMID: 36652917
PMC: 9873932.
DOI: 10.1016/j.xcrm.2022.100908.
Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis.
Aiyer K, Doeleman T, Ryan N, Nielsen M, Crosbie E, Smit V
Mod Pathol. 2022; 35(12):1775-1783.
PMID: 36104536
PMC: 9708570.
DOI: 10.1038/s41379-022-01149-w.
ATF6 prevents DNA damage and cell death in colon cancer cells undergoing ER stress.
Benedetti R, Romeo M, Arena A, Gilardini Montani M, Di Renzo L, DOrazi G
Cell Death Discov. 2022; 8(1):295.
PMID: 35752616
PMC: 9233702.
DOI: 10.1038/s41420-022-01085-3.